Boasting a 70% price increase over the last 12 weeks with a low forward PE of 4.58.

In volatile conditions, analysts often pivot to consumer staples and healthcare for "total return" potential with lower risk:

Estimated to be trading at a nearly 50% discount to its fair value of $24.07.

Up 33% recently, supported by strong projected earnings growth of over 48%.

For investors looking for a "bounce" or mean reversion, these stocks are currently trading at significant discounts to their estimated fair value: